Quick Dispatch:
Your foxo4-dri peptide senolytic human trial FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri peptide senolytic human trial FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells ships.
Need Help?
Questions about foxo4-dri peptide senolytic human trial FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri peptide senolytic human trial FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells in your area.
FOXO4-DRI (Proxofim)
29.22
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
21.22
foxo4-dri human clinical trial FOXO4-DRI 10mg Research Peptide
26.75
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
24.07
Class II senolytics inhibit survival pathways elicited by senescent
28.53
TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS • The Journal of Prevention of Alzheimer's Disease
27.99
Frontiers
24.58
